The Leap-In Transposase® platform from ATUM is a comprehensive bioengineered solution for the fast, efficient, stable and robust expression of recombinant proteins in mammalian cells.
Learn how using the Leap-In Transposase platform in conjunction with Solentim's cell line development instruments, means that the majority of the clones from the selected population are high-producers, bypassing the need for high throughput screening.
Please complete the form below and we will send you the brochure